Industry17h ago
FDA Pilots AI For Real-Time Trial Monitoring
The FDA is launching a pilot program using AI and cloud computing to monitor clinical trials in real time. This shift aims to accelerate drug approval timelines. The agency implements these tools to maintain oversight following DOGE layoffs. Practitioners can expect faster regulatory feedback loops and digitized compliance checks during the trial phase.